USE OF SULFATED OLIGOSACCHARIDES IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER SURGICAL RESECTION

A use of sulfated oligosaccharides in the manufacture of a medicament for reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma (HCC) patient with microvascular invasion after curative liver resection, while excluding HCC patients with no va...

Full description

Saved in:
Bibliographic Details
Main Authors CHANG, Stanley, LAI, Kuan-lang
Format Patent
LanguageEnglish
French
Published 07.09.2018
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A use of sulfated oligosaccharides in the manufacture of a medicament for reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma (HCC) patient with microvascular invasion after curative liver resection, while excluding HCC patients with no vascular invasion and HCC patients with macrovascular invasion is provided. La présente invention concerne l'utilisation d'oligosaccharides sulfatés dans la fabrication d'un médicament permettant de réduire la récurrence d'une tumeur intrahépatique et d'accroître la période de survie sans maladie chez un patient atteint d'un carcinome hépatocellulaire (HCC) présentant une invasion microvasculaire après résection hépatique curative, tout en excluant les patients atteints d'HCC sans invasion vasculaire et les patients atteints d'HCC présentant une invasion macrovasculaire.
Bibliography:Application Number: WO2018CN77105